このエピソードについて
touchCONGRESS for touchONCOLOGY
Listen to key highlights from ESMO Virtual 2020. This touchPODCAST is presented by Dr Catherine Kelly.
We specifically focus on data presented at this congress describing CDK4/6 inhibitors in HR+/HER2- breast cancer and what these data could mean for clinical practice.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Eli Lilly. This activity is provided by touchIME.
For further information visit our website: https://touchoncologyime.org/hrher2-breastcanceresmo2020touchcongress/
英語
アメリカ合衆国
文字起こし 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
このポッドキャストの他のエピソード
Dr. Melinda Gooderham, Prof. Dr. Falk Bechara, and Dr. Daniel Stein discuss how evolving therapies are reshaping HS management and multidisciplinary care, with patient perspectives highlighting the impact of coordinated care and effective disease control.
The multidisciplinary team
Dr. Melinda …
Dr. Melinda Gooderham, Prof. Dr. Falk Bechara, and Dr. Daniel Stein discuss the medical and surgical decision-making challenges in perineal and genital HS, including common diagnostic pitfalls, how to integrate medical and surgical treatment, and the unique role of urology in managing complex disea…
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to an interview with Dr. Christine Kay on the role of vitamin A in the retina, how vitamin A processing is disrupted in Stargardt disease, and the mechanism of action, emerging clinical evidence, and key safety considerations for emerging oral therap…
touchPANEL DISCUSSION for touchNEUROLOGY
Hear from three experts as they share practical insights into recognizing and diagnosing Lennox–Gastaut syndrome across the lifespan, navigating the complexities of polytherapy, and addressing the cognitive, behavioral, functional, and quality of life chall…
touchIN CONVERSATION for touchNEUROLOGY and touchONCOLOGY
Management of neurofibromatosis type 1 (NF1)–associated plexiform neurofibromas in adults requires individualized decisions that account for symptoms, function, resectability and patient goals. Listen to NF1 experts Prof. Allan Belzberg, a …
免責: このページに埋め込まれているポッドキャストとアートワークは touchpodcast からのものであり、その所有者の所有物であり、Listen Notes, Inc. と提携または承認されていません。
